AI assistant
FLUENCE CORPORATION LIMITED — Capital/Financing Update 2021
Oct 14, 2021
64922_rns_2021-10-14_fe11367b-91a0-4b97-b3ab-52aac7c81035.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [144 x 58] intentionally omitted <==
15 October 2021
Fluence Secures US$8.5M MABR Order in Cambodia
-
Largest MABR plant to date will treat wastewater for 160,000 people
-
Due to commence operation in H1 2022
-
Third MABR plant in Cambodia
-
X-WATER to be Fluence’s exclusive partner in Cambodia
Fluence Corporation (ASX:FLC) is pleased to announce that it has won an US $8.5M contract from the Cambodian Government’s Ministry of Land Management, Urban Planning and Construction, to build a third SUBRE plant using MABR technology in Sihanoukville, Cambodia. The SUBRE plant will consist of 90 three-tier MABR stacks, each consisting of three MABR spirals in a tower configuration, treating wastewater for a population of 160,000. Fluence will again team with engineering partner X-WATER, following successful collaborations on the first two SUBRE plants now operating successfully in Sihanoukville. These initial plants are the first biological treatment plants of any kind in Cambodia.
Commenting on this important win, Fluence Chairman and Chief Executive Officer Richard Irving said: “Fluence’s MABR is ideally suited to meet the Cambodian government’s push for higher treatment standards. This contract is testament to MABR’s scalable performance, favorable cost and just in time deployment. Moreover, it provides further operating proof that supports the North American business model of large scale wastewater treatment and reuse as a service, since our MABR solution delivers top quality treatment at minimum cost and energy in large as well as small plants. We are very pleased to secure this contract for our third major MABR plant in the country and to again work with XWATER. Our partnership has already garnered national attention with excellent results from our first two plants. We are delighted XWATER has agreed to be our exclusive partner in Cambodia. We anticipate future projects in the region to utilize Aspiral systems as well as SUBRE configurations of MABR.”
1
==> picture [244 x 166] intentionally omitted <==
==> picture [174 x 247] intentionally omitted <==
==> picture [228 x 149] intentionally omitted <==
==> picture [214 x 149] intentionally omitted <==
Left: first two SUBRE MABR plants operating in Sihanoukville, Cambodia. Top right: proposed layout of new plant outlined in red. Bottom right: site preparations for new plant.
This announcement is authorised for lodgement on the ASX by Richard Irving, Chairman & CEO, Fluence Corporation Limited.
ENDS-
USA 10 Bank Street, Suite 830 White Plains, NY, 10606 ABN: 52 127 734 196 Phone: +1-212-572-5700 www.fluencecorp.com Facsimile: +1-212-572-5704
Fluence Corporation Limited
AUSTRALIA Level 4, 96-100 Albert Road, South Melbourne, Victoria 3205 Phone: + 61 3 9692 7222
2
For further information, please contact:
Australia Andrew Angus Investor Relations E: [email protected] P: +61 402 823 757
United States of America Richard Irving Chairman and CEO E: [email protected]
About Fluence Corporation Limited (ASX: FLC)
Fluence is a leader in the decentralized water, wastewater and reuse treatment markets, with its preengineered, standardized Smart Products Solutions, including Aspiral™, NIROBOX™ and SUBRE. In addition to rapid delivery and commissioning of decentralized solutions to meet a broad range of needs, Fluence offers ongoing operation and maintenance support, as well as Build Own Operate Transfer (BOOT) and other recurring revenue solutions. Fluence has a broad international footprint and focuses on high growth markets including China, the Middle East, Southeast Asia, and North America. Further information can be found at https://www.fluencecorp.com/
Forward looking statements
“This quarterly business update contains “forward-looking” statements. Forward looking words, such as “expect”, “anticipate”, “should”, “could”, “may”, “predict”, “plan”, “will”, “believe”, “forecast”, “estimate”, “target” and other similar expressions are intended to identify forward-looking statements. Forward-looking statements, opinions and estimates provided in this update are based on estimates and assumptions related to future business, contractual, economic, market, political and other conditions that, while Fluence considers them to be reasonable, are inherently subject to significant uncertainties, contingencies and (potentially) delays.
Many known and unknown factors could cause actual events or results to differ materially from estimated or anticipated events or results reflected in such forward-looking statements. Such factors include, but are not limited to operating, competition and development risks, economic and political risks, economic uncertainty associated with COVID-19, and a number of other risks and also include unanticipated and unusual events, many of which are beyond Fluence's ability to control or predict.
USA
10 Bank Street, Suite 830 White Plains, NY, 10606 Phone: +1-212-572-5700 Facsimile: +1-212-572-5704
AUSTRALIA
Level 4, 96-100 Albert Road, South Melbourne, VIC 3205 Phone: +61 3 9692 7222 Facsimile: +61 3 9077 9233
Fluence Corporation Limited
ABN: 52 127 734 196 www.fluencecorp.com
3